aluates Reports

$ 0.0

Automative

Global Feline Infectious Peritonitis (FIP) Antivirals Market Research Report 2025

Published Date: November 2025

Report Code: QYRE-Auto-4U20267

BUY CHAPTERS

Global Feline Infectious Peritonitis (FIP) Antivirals Market Research Report 2025

Code: QYRE-Auto-4U20267

Report

November 2025

Pages:68

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Feline Infectious Peritonitis (FIP) Antivirals Market Size

The global market for Feline Infectious Peritonitis (FIP) Antivirals was valued at US$ 44.00 million in the year 2024 and is projected to reach a revised size of US$ 195 million by 2031, growing at a CAGR of 22.0% during the forecast period.

Feline Infectious Peritonitis (FIP) Antivirals Market

Feline Infectious Peritonitis (FIP) Antivirals are drugs developed to treat feline infectious peritonitis caused by mutated feline coronavirus. These agents primarily act by inhibiting viral replication, blocking viral protease activity, or interfering with viral RNA synthesis. Representative compounds include the nucleoside analog GS-441524 and the protease inhibitor GC376. Some antiviral candidates have demonstrated remarkable clinical efficacy in experimental and field studies. The development of FIP antivirals represents a significant advance in feline virology and marks a key area of innovation in the veterinary pharmaceutical industry.

North American market for Feline Infectious Peritonitis (FIP) Antivirals is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Feline Infectious Peritonitis (FIP) Antivirals is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Feline Infectious Peritonitis (FIP) Antivirals in Pet Hospitals is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Feline Infectious Peritonitis (FIP) Antivirals include Bova Group, Anivive Lifesciences, Wedgewood, Gilead Sciences, Mutian Biotechnology, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Feline Infectious Peritonitis (FIP) Antivirals, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Feline Infectious Peritonitis (FIP) Antivirals.

The Feline Infectious Peritonitis (FIP) Antivirals market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Feline Infectious Peritonitis (FIP) Antivirals market comprehensively. Regional market sizes, concerning products by Type, by Application, by Mechanism and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Feline Infectious Peritonitis (FIP) Antivirals companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Feline Infectious Peritonitis (FIP) Antivirals Market Report

Report Metric	Details
Report Name	Feline Infectious Peritonitis (FIP) Antivirals Market
Accounted market size in year	US$ 44.00 million
Forecasted market size in 2031	US$ 195 million
CAGR	22.0%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Oral Drugs Injectable Drugs
Segment by Mechanism	Nucleoside Analogues Protein Inhibitors Immunomotors Others
Segment by Application	Pet Hospitals Online Pharmacies Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Bova Group, Anivive Lifesciences, Wedgewood, Gilead Sciences, Mutian Biotechnology
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, by Mechanism etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Feline Infectious Peritonitis (FIP) Antivirals company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Feline Infectious Peritonitis (FIP) Antivirals Market growing?

Ans: The Feline Infectious Peritonitis (FIP) Antivirals Market witnessing a CAGR of 22.0% during the forecast period 2025-2031.

What is the Feline Infectious Peritonitis (FIP) Antivirals Market size in 2031?

Ans: The Feline Infectious Peritonitis (FIP) Antivirals Market size in 2031 will be US$ 195 million.

Who are the main players in the Feline Infectious Peritonitis (FIP) Antivirals Market report?

Ans: The main players in the Feline Infectious Peritonitis (FIP) Antivirals Market are Bova Group, Anivive Lifesciences, Wedgewood, Gilead Sciences, Mutian Biotechnology

What are the Application segmentation covered in the Feline Infectious Peritonitis (FIP) Antivirals Market report?

Ans: The Applications covered in the Feline Infectious Peritonitis (FIP) Antivirals Market report are Pet Hospitals, Online Pharmacies, Others

What are the Type segmentation covered in the Feline Infectious Peritonitis (FIP) Antivirals Market report?

Ans: The Types covered in the Feline Infectious Peritonitis (FIP) Antivirals Market report are Oral Drugs, Injectable Drugs

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Feline Infectious Peritonitis (FIP) Antivirals Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Oral Drugs

1.2.3 Injectable Drugs

1.3 Market by Mechanism

1.3.1 Global Feline Infectious Peritonitis (FIP) Antivirals Market Size Growth Rate by Mechanism: 2020 VS 2024 VS 2031

1.3.2 Nucleoside Analogues

1.3.3 Protein Inhibitors

1.3.4 Immunomotors

1.3.5 Others

1.4 Market by Application

1.4.1 Global Feline Infectious Peritonitis (FIP) Antivirals Market Growth by Application: 2020 VS 2024 VS 2031

1.4.2 Pet Hospitals

1.4.3 Online Pharmacies

1.4.4 Others

1.5 Assumptions and Limitations

1.6 Study Objectives

1.7 Years Considered

2 Global Growth Trends

2.1 Global Feline Infectious Peritonitis (FIP) Antivirals Market Perspective (2020-2031)

2.2 Global Feline Infectious Peritonitis (FIP) Antivirals Growth Trends by Region

2.2.1 Global Feline Infectious Peritonitis (FIP) Antivirals Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Feline Infectious Peritonitis (FIP) Antivirals Historic Market Size by Region (2020-2025)

2.2.3 Feline Infectious Peritonitis (FIP) Antivirals Forecasted Market Size by Region (2026-2031)

2.3 Feline Infectious Peritonitis (FIP) Antivirals Market Dynamics

2.3.1 Feline Infectious Peritonitis (FIP) Antivirals Industry Trends

2.3.2 Feline Infectious Peritonitis (FIP) Antivirals Market Drivers

2.3.3 Feline Infectious Peritonitis (FIP) Antivirals Market Challenges

2.3.4 Feline Infectious Peritonitis (FIP) Antivirals Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Feline Infectious Peritonitis (FIP) Antivirals Players by Revenue

3.1.1 Global Top Feline Infectious Peritonitis (FIP) Antivirals Players by Revenue (2020-2025)

3.1.2 Global Feline Infectious Peritonitis (FIP) Antivirals Revenue Market Share by Players (2020-2025)

3.2 Global Top Feline Infectious Peritonitis (FIP) Antivirals Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Feline Infectious Peritonitis (FIP) Antivirals Revenue

3.4 Global Feline Infectious Peritonitis (FIP) Antivirals Market Concentration Ratio

3.4.1 Global Feline Infectious Peritonitis (FIP) Antivirals Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Feline Infectious Peritonitis (FIP) Antivirals Revenue in 2024

3.5 Global Key Players of Feline Infectious Peritonitis (FIP) Antivirals Head office and Area Served

3.6 Global Key Players of Feline Infectious Peritonitis (FIP) Antivirals, Product and Application

3.7 Global Key Players of Feline Infectious Peritonitis (FIP) Antivirals, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Feline Infectious Peritonitis (FIP) Antivirals Breakdown Data by Type

4.1 Global Feline Infectious Peritonitis (FIP) Antivirals Historic Market Size by Type (2020-2025)

4.2 Global Feline Infectious Peritonitis (FIP) Antivirals Forecasted Market Size by Type (2026-2031)

5 Feline Infectious Peritonitis (FIP) Antivirals Breakdown Data by Application

5.1 Global Feline Infectious Peritonitis (FIP) Antivirals Historic Market Size by Application (2020-2025)

5.2 Global Feline Infectious Peritonitis (FIP) Antivirals Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Feline Infectious Peritonitis (FIP) Antivirals Market Size (2020-2031)

6.2 North America Feline Infectious Peritonitis (FIP) Antivirals Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Feline Infectious Peritonitis (FIP) Antivirals Market Size by Country (2020-2025)

6.4 North America Feline Infectious Peritonitis (FIP) Antivirals Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Feline Infectious Peritonitis (FIP) Antivirals Market Size (2020-2031)

7.2 Europe Feline Infectious Peritonitis (FIP) Antivirals Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Feline Infectious Peritonitis (FIP) Antivirals Market Size by Country (2020-2025)

7.4 Europe Feline Infectious Peritonitis (FIP) Antivirals Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Feline Infectious Peritonitis (FIP) Antivirals Market Size (2020-2031)

8.2 Asia-Pacific Feline Infectious Peritonitis (FIP) Antivirals Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Feline Infectious Peritonitis (FIP) Antivirals Market Size by Region (2020-2025)

8.4 Asia-Pacific Feline Infectious Peritonitis (FIP) Antivirals Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Feline Infectious Peritonitis (FIP) Antivirals Market Size (2020-2031)

9.2 Latin America Feline Infectious Peritonitis (FIP) Antivirals Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Feline Infectious Peritonitis (FIP) Antivirals Market Size by Country (2020-2025)

9.4 Latin America Feline Infectious Peritonitis (FIP) Antivirals Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Feline Infectious Peritonitis (FIP) Antivirals Market Size (2020-2031)

10.2 Middle East & Africa Feline Infectious Peritonitis (FIP) Antivirals Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Feline Infectious Peritonitis (FIP) Antivirals Market Size by Country (2020-2025)

10.4 Middle East & Africa Feline Infectious Peritonitis (FIP) Antivirals Market Size by Country (2026-2031)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Bova Group

11.1.1 Bova Group Company Details

11.1.2 Bova Group Business Overview

11.1.3 Bova Group Feline Infectious Peritonitis (FIP) Antivirals Introduction

11.1.4 Bova Group Revenue in Feline Infectious Peritonitis (FIP) Antivirals Business (2020-2025)

11.1.5 Bova Group Recent Development

11.2 Anivive Lifesciences

11.2.1 Anivive Lifesciences Company Details

11.2.2 Anivive Lifesciences Business Overview

11.2.3 Anivive Lifesciences Feline Infectious Peritonitis (FIP) Antivirals Introduction

11.2.4 Anivive Lifesciences Revenue in Feline Infectious Peritonitis (FIP) Antivirals Business (2020-2025)

11.2.5 Anivive Lifesciences Recent Development

11.3 Wedgewood

11.3.1 Wedgewood Company Details

11.3.2 Wedgewood Business Overview

11.3.3 Wedgewood Feline Infectious Peritonitis (FIP) Antivirals Introduction

11.3.4 Wedgewood Revenue in Feline Infectious Peritonitis (FIP) Antivirals Business (2020-2025)

11.3.5 Wedgewood Recent Development

11.4 Gilead Sciences

11.4.1 Gilead Sciences Company Details

11.4.2 Gilead Sciences Business Overview

11.4.3 Gilead Sciences Feline Infectious Peritonitis (FIP) Antivirals Introduction

11.4.4 Gilead Sciences Revenue in Feline Infectious Peritonitis (FIP) Antivirals Business (2020-2025)

11.4.5 Gilead Sciences Recent Development

11.5 Mutian Biotechnology

11.5.1 Mutian Biotechnology Company Details

11.5.2 Mutian Biotechnology Business Overview

11.5.3 Mutian Biotechnology Feline Infectious Peritonitis (FIP) Antivirals Introduction

11.5.4 Mutian Biotechnology Revenue in Feline Infectious Peritonitis (FIP) Antivirals Business (2020-2025)

11.5.5 Mutian Biotechnology Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Feline Infectious Peritonitis (FIP) Antivirals Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Oral Drugs

Table 3. Key Players of Injectable Drugs

Table 4. Global Feline Infectious Peritonitis (FIP) Antivirals Market Size Growth Rate by Mechanism (US$ Million): 2020 VS 2024 VS 2031

Table 5. Key Players of Nucleoside Analogues

Table 6. Key Players of Protein Inhibitors

Table 7. Key Players of Immunomotors

Table 8. Key Players of Others

Table 9. Global Feline Infectious Peritonitis (FIP) Antivirals Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 10. Global Feline Infectious Peritonitis (FIP) Antivirals Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 11. Global Feline Infectious Peritonitis (FIP) Antivirals Market Size by Region (2020-2025) & (US$ Million)

Table 12. Global Feline Infectious Peritonitis (FIP) Antivirals Market Share by Region (2020-2025)

Table 13. Global Feline Infectious Peritonitis (FIP) Antivirals Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 14. Global Feline Infectious Peritonitis (FIP) Antivirals Market Share by Region (2026-2031)

Table 15. Feline Infectious Peritonitis (FIP) Antivirals Market Trends

Table 16. Feline Infectious Peritonitis (FIP) Antivirals Market Drivers

Table 17. Feline Infectious Peritonitis (FIP) Antivirals Market Challenges

Table 18. Feline Infectious Peritonitis (FIP) Antivirals Market Restraints

Table 19. Global Feline Infectious Peritonitis (FIP) Antivirals Revenue by Players (2020-2025) & (US$ Million)

Table 20. Global Feline Infectious Peritonitis (FIP) Antivirals Market Share by Players (2020-2025)

Table 21. Global Top Feline Infectious Peritonitis (FIP) Antivirals Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Feline Infectious Peritonitis (FIP) Antivirals as of 2024)

Table 22. Ranking of Global Top Feline Infectious Peritonitis (FIP) Antivirals Companies by Revenue (US$ Million) in 2024

Table 23. Global 5 Largest Players Market Share by Feline Infectious Peritonitis (FIP) Antivirals Revenue (CR5 and HHI) & (2020-2025)

Table 24. Global Key Players of Feline Infectious Peritonitis (FIP) Antivirals, Headquarters and Area Served

Table 25. Global Key Players of Feline Infectious Peritonitis (FIP) Antivirals, Product and Application

Table 26. Global Key Players of Feline Infectious Peritonitis (FIP) Antivirals, Date of Enter into This Industry

Table 27. Mergers & Acquisitions, Expansion Plans

Table 28. Global Feline Infectious Peritonitis (FIP) Antivirals Market Size by Type (2020-2025) & (US$ Million)

Table 29. Global Feline Infectious Peritonitis (FIP) Antivirals Revenue Market Share by Type (2020-2025)

Table 30. Global Feline Infectious Peritonitis (FIP) Antivirals Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 31. Global Feline Infectious Peritonitis (FIP) Antivirals Revenue Market Share by Type (2026-2031)

Table 32. Global Feline Infectious Peritonitis (FIP) Antivirals Market Size by Application (2020-2025) & (US$ Million)

Table 33. Global Feline Infectious Peritonitis (FIP) Antivirals Revenue Market Share by Application (2020-2025)

Table 34. Global Feline Infectious Peritonitis (FIP) Antivirals Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 35. Global Feline Infectious Peritonitis (FIP) Antivirals Revenue Market Share by Application (2026-2031)

Table 36. North America Feline Infectious Peritonitis (FIP) Antivirals Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. North America Feline Infectious Peritonitis (FIP) Antivirals Market Size by Country (2020-2025) & (US$ Million)

Table 38. North America Feline Infectious Peritonitis (FIP) Antivirals Market Size by Country (2026-2031) & (US$ Million)

Table 39. Europe Feline Infectious Peritonitis (FIP) Antivirals Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 40. Europe Feline Infectious Peritonitis (FIP) Antivirals Market Size by Country (2020-2025) & (US$ Million)

Table 41. Europe Feline Infectious Peritonitis (FIP) Antivirals Market Size by Country (2026-2031) & (US$ Million)

Table 42. Asia-Pacific Feline Infectious Peritonitis (FIP) Antivirals Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 43. Asia-Pacific Feline Infectious Peritonitis (FIP) Antivirals Market Size by Region (2020-2025) & (US$ Million)

Table 44. Asia-Pacific Feline Infectious Peritonitis (FIP) Antivirals Market Size by Region (2026-2031) & (US$ Million)

Table 45. Latin America Feline Infectious Peritonitis (FIP) Antivirals Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Latin America Feline Infectious Peritonitis (FIP) Antivirals Market Size by Country (2020-2025) & (US$ Million)

Table 47. Latin America Feline Infectious Peritonitis (FIP) Antivirals Market Size by Country (2026-2031) & (US$ Million)

Table 48. Middle East & Africa Feline Infectious Peritonitis (FIP) Antivirals Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 49. Middle East & Africa Feline Infectious Peritonitis (FIP) Antivirals Market Size by Country (2020-2025) & (US$ Million)

Table 50. Middle East & Africa Feline Infectious Peritonitis (FIP) Antivirals Market Size by Country (2026-2031) & (US$ Million)

Table 51. Bova Group Company Details

Table 52. Bova Group Business Overview

Table 53. Bova Group Feline Infectious Peritonitis (FIP) Antivirals Product

Table 54. Bova Group Revenue in Feline Infectious Peritonitis (FIP) Antivirals Business (2020-2025) & (US$ Million)

Table 55. Bova Group Recent Development

Table 56. Anivive Lifesciences Company Details

Table 57. Anivive Lifesciences Business Overview

Table 58. Anivive Lifesciences Feline Infectious Peritonitis (FIP) Antivirals Product

Table 59. Anivive Lifesciences Revenue in Feline Infectious Peritonitis (FIP) Antivirals Business (2020-2025) & (US$ Million)

Table 60. Anivive Lifesciences Recent Development

Table 61. Wedgewood Company Details

Table 62. Wedgewood Business Overview

Table 63. Wedgewood Feline Infectious Peritonitis (FIP) Antivirals Product

Table 64. Wedgewood Revenue in Feline Infectious Peritonitis (FIP) Antivirals Business (2020-2025) & (US$ Million)

Table 65. Wedgewood Recent Development

Table 66. Gilead Sciences Company Details

Table 67. Gilead Sciences Business Overview

Table 68. Gilead Sciences Feline Infectious Peritonitis (FIP) Antivirals Product

Table 69. Gilead Sciences Revenue in Feline Infectious Peritonitis (FIP) Antivirals Business (2020-2025) & (US$ Million)

Table 70. Gilead Sciences Recent Development

Table 71. Mutian Biotechnology Company Details

Table 72. Mutian Biotechnology Business Overview

Table 73. Mutian Biotechnology Feline Infectious Peritonitis (FIP) Antivirals Product

Table 74. Mutian Biotechnology Revenue in Feline Infectious Peritonitis (FIP) Antivirals Business (2020-2025) & (US$ Million)

Table 75. Mutian Biotechnology Recent Development

Table 76. Research Programs/Design for This Report

Table 77. Key Data Information from Secondary Sources

Table 78. Key Data Information from Primary Sources

Table 79. Authors List of This Report

List of Figures

Figure 1. Feline Infectious Peritonitis (FIP) Antivirals Picture

Figure 2. Global Feline Infectious Peritonitis (FIP) Antivirals Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Feline Infectious Peritonitis (FIP) Antivirals Market Share by Type: 2024 VS 2031

Figure 4. Oral Drugs Features

Figure 5. Injectable Drugs Features

Figure 6. Global Feline Infectious Peritonitis (FIP) Antivirals Market Size Comparison by Mechanism (2020-2031) & (US$ Million)

Figure 7. Nucleoside Analogues Features

Figure 8. Protein Inhibitors Features

Figure 9. Immunomotors Features

Figure 10. Others Features

Figure 11. Global Feline Infectious Peritonitis (FIP) Antivirals Market Size by Application (2020-2031) & (US$ Million)

Figure 12. Global Feline Infectious Peritonitis (FIP) Antivirals Market Share by Application: 2024 VS 2031

Figure 13. Pet Hospitals Case Studies

Figure 14. Online Pharmacies Case Studies

Figure 15. Others Case Studies

Figure 16. Feline Infectious Peritonitis (FIP) Antivirals Report Years Considered

Figure 17. Global Feline Infectious Peritonitis (FIP) Antivirals Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 18. Global Feline Infectious Peritonitis (FIP) Antivirals Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 19. Global Feline Infectious Peritonitis (FIP) Antivirals Market Share by Region: 2024 VS 2031

Figure 20. Global Feline Infectious Peritonitis (FIP) Antivirals Market Share by Players in 2024

Figure 21. Global Feline Infectious Peritonitis (FIP) Antivirals Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 22. The Top 10 and 5 Players Market Share by Feline Infectious Peritonitis (FIP) Antivirals Revenue in 2024

Figure 23. North America Feline Infectious Peritonitis (FIP) Antivirals Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. North America Feline Infectious Peritonitis (FIP) Antivirals Market Share by Country (2020-2031)

Figure 25. United States Feline Infectious Peritonitis (FIP) Antivirals Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Canada Feline Infectious Peritonitis (FIP) Antivirals Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Europe Feline Infectious Peritonitis (FIP) Antivirals Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Europe Feline Infectious Peritonitis (FIP) Antivirals Market Share by Country (2020-2031)

Figure 29. Germany Feline Infectious Peritonitis (FIP) Antivirals Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. France Feline Infectious Peritonitis (FIP) Antivirals Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. U.K. Feline Infectious Peritonitis (FIP) Antivirals Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Italy Feline Infectious Peritonitis (FIP) Antivirals Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Russia Feline Infectious Peritonitis (FIP) Antivirals Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Ireland Feline Infectious Peritonitis (FIP) Antivirals Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Asia-Pacific Feline Infectious Peritonitis (FIP) Antivirals Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Asia-Pacific Feline Infectious Peritonitis (FIP) Antivirals Market Share by Region (2020-2031)

Figure 37. China Feline Infectious Peritonitis (FIP) Antivirals Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Japan Feline Infectious Peritonitis (FIP) Antivirals Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. South Korea Feline Infectious Peritonitis (FIP) Antivirals Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Southeast Asia Feline Infectious Peritonitis (FIP) Antivirals Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. India Feline Infectious Peritonitis (FIP) Antivirals Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Australia & New Zealand Feline Infectious Peritonitis (FIP) Antivirals Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Latin America Feline Infectious Peritonitis (FIP) Antivirals Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Latin America Feline Infectious Peritonitis (FIP) Antivirals Market Share by Country (2020-2031)

Figure 45. Mexico Feline Infectious Peritonitis (FIP) Antivirals Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Brazil Feline Infectious Peritonitis (FIP) Antivirals Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Middle East & Africa Feline Infectious Peritonitis (FIP) Antivirals Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Middle East & Africa Feline Infectious Peritonitis (FIP) Antivirals Market Share by Country (2020-2031)

Figure 49. Israel Feline Infectious Peritonitis (FIP) Antivirals Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Saudi Arabia Feline Infectious Peritonitis (FIP) Antivirals Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. UAE Feline Infectious Peritonitis (FIP) Antivirals Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 52. Bova Group Revenue Growth Rate in Feline Infectious Peritonitis (FIP) Antivirals Business (2020-2025)

Figure 53. Anivive Lifesciences Revenue Growth Rate in Feline Infectious Peritonitis (FIP) Antivirals Business (2020-2025)

Figure 54. Wedgewood Revenue Growth Rate in Feline Infectious Peritonitis (FIP) Antivirals Business (2020-2025)

Figure 55. Gilead Sciences Revenue Growth Rate in Feline Infectious Peritonitis (FIP) Antivirals Business (2020-2025)

Figure 56. Mutian Biotechnology Revenue Growth Rate in Feline Infectious Peritonitis (FIP) Antivirals Business (2020-2025)

Figure 57. Bottom-up and Top-down Approaches for This Report

Figure 58. Data Triangulation

Figure 59. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions